Aside from clinical staging, previous studies have identified CD38, ZAP‐70, cytogenetic abnormality, serum β2‐microglobulin (β2‐MG), and serum lactate dehydrogenase (LDH) as prognostic factors for CLL.1, 17. Here, ZAP70 is linked to B-cell chronic lymphocytic leukemia.